WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
6th - 9th October
ICC Wales
Abstract Submission Open
Registration Open!
BASL2026 is supported by sponsors including pharmaceutical companies - a full declaration and list of sponsors can be found HERE
BASL ANNUAL MEETING
6th-9th October 2026
BASL ANNUAL MEETING 2026 - Registration Open
Tuesday 6th - Friday 9th October - including: BLTG Transplant Meeting and BLNA Nurse meeting.
International Convention Centre, Newport, Wales.
Abstract submission deadline extended to 12pm 12th June!
Full details here: https://baslannualmeeting.org.uk/
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
Save the Date: North vs South UK Cricket Match Sunday 12th July
Read moreNorth vs South cricket match, raising funds for the British Liver Trust
Sunday 12th July 2026, York Cricket Club, York
11:00 – 16:00 (time TBC)
All Welcome!
Tombola/Raffle/stalls
If you wish to play for the North please contact Dr Joanna Moore (Joanna.moore@nhs.net)
If you wish to play for the South please contact Dr Gautam Mehta (gautam.mehta@ucl.ac.uk )
Gilead UK & Ireland 2026 Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme is now open
Read moreOn behalf of Gilead Sciences Ltd.
The Gilead UK & Ireland Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme funds innovative projects and initiatives that can ultimately lead to an improvement in awareness and diagnosis of viral hepatitis (B, C and Delta) and/or demonstrate the proof of concept/pilot Opt-Out testing of BBV (HBV, HCV, HDV and HIV).
Applications are invited from healthcare and third sector organisations (e.g., charities) who are seeking funding for a project that aligns with the goals of the programme. Please be advised that only health-related organisations are eligible to receive grants through this application process. Individual applicants are not eligible for funding.
The programme is looking to support innovative projects and initiatives that:
- Improve awareness and diagnosis of viral hepatitis (B, C, and Delta), including among migrant and other underserved communities
- Demonstrate proof of concept and/or pilot opt-out BBV testing across a broader range of healthcare and community settings where high prevalence rates of HBV, HCV, HDV and HIV are expected (e.g., primary care, women’s health hubs, psychiatry services, migrant health services, and services targeting underserved populations)
- Optimise linkage to care and/or management for people living with viral hepatitis (B, C, and Delta), including peer support
- Evaluate innovative approaches to optimising patient pathways and enabling rapid access to care for those newly diagnosed with viral hepatitis (B, C, and Delta)
- Enhance patient support programmes and tools for people living with viral hepatitis (B, C, and Delta), with a focus on addressing stigma, community outreach and engagement, disease awareness, and prevention of transmission
- Improve understanding of, and reduce, variations in care for people living with viral hepatitis (B, C, and Delta), and improve the experiences of people from marginalised communities
- Improve the use of data to diagnose people with viral hepatitis (B, C, and Delta) and to identify those lost to follow-up
- Assess the societal and health economic implications of hepatitis B and Delta
The application window will close on Friday 22nd May 2026. More information about the Gilead UK & Ireland Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme, is available on the Gilead UK and Ireland website > HERE.
Any questions regarding the process or the application form can be directed to gileadfellowship@axon-com.com .
Date of prepartion: April 2026
Code: UKI-UNB-2707
Optimizing Multidisciplinary Team (MDT) Working in Hepatobiliary (HB) Oncology Survey
Read moreThis survey is intended for clinicians and allied health care professionals to help inform current provision of MDT practice in the UK and ultimately to inform best practice. The purpose of the project is intended predominantly to apply to HB cancer MDTs, although other forms of MDT and cancer MDTs may be touched on. It intends to map current practice and attitudes to HB cancer MDTs. More importantly it aims to identify inequalities in access to care and expertise and to provide universal standards that can be applied across the NHS and perhaps wider healthcare systems.
The survey will be derived from UK MDT centres whilst a separate Delphi process will be generated through a multi-disciplinary body of experts (medical, nursing, AHPs) across the specialties, and also patients and patient groups and charities. As an endpoint, the working group wants their findings to be published in a peer-reviewed journal and to be disseminated to National bodies, e.g. NHS bodies in England, Northern Ireland, Scotland and Wales, along with Cancer alliances and NHS trusts.
Please complete the survey and forward it to other members of your MDT, including surgeons, medical and clinical oncologists, clinical nurse specialists, radiologists (diagnostic and interventional), histopathologists, gastroenterologists, hepatologists and other allied health professionals who are involved in HB care.
The survey may take 10-15 minutes to complete but it is important we get as many responses as possible so completion would be appreciated.
Survey link: https://www.surveymonkey.com/r/KYHBDSV
The closing date for completion of the survey is 3rd June 2026.
Contact admin@basl.org.uk for any questions.
Thank you for taking part.
Kind regards,
Tim Cross
Past President BASL
BASL Special Interest Group (SIG) Lead Nominations Round Open
Read moreBASL is seeking nominations for a number of Special Interest Group (SIG) Leads as the current leads have come to the end of their tenure. These SIGs are linked to the NIHR’s Research Delivery Network (RDN) topic areas.
SIG Leads will serve for two years and the posts currently up for change are as listed below:
- Acute Liver Failure (ALF) SIG
- Alcohol related Liver Disease (ArLD) SIG
- Cholangiocarcinoma-UK (CCA-UK) SIG
- Immune-Mediated Liver Disease SIG
- Metabolic Dysfunction–Associated Liver Disease (MASLD) SIG
- Palliative Hepatology SIG
- Portal Hypertension SIG
- Rare Diseases SIG
NB: SIG Leads are required to be a BASL member.
Further information for each of the SIGs may be found on the BASL website HERE
The role of the SIG Lead can be found in the BASL/BSG Special Interest Groups (SIGs) Terms of Reference Download SIGs_generic_terms_of_reference_2026.pdf
Eligibility requirements
- Candidates wishing to be considered for nomination must be a BASL member or a member of the relevant SIG their nomination is for.
- Each candidate must have a proposer and seconder, who should also be a BASL member or an associate member through the relevant SIG.
Nomination process
- Please send nominations by email clearly stating the SIG Lead position that your nomination is for to the BASL Secretariat at sigs@basl.org.uk by 17:00 on 12th May 2026.
- Candidates wishing to be considered for nomination must be a member of BASL and will require one BASL / SIG member to propose them and a second BASL / SIG member to second their nomination.
- If only one candidate is proposed and seconded, that candidate will be elected unopposed as the appropriate SIG Lead.
- If two or more candidates are nominated, eligible candidates will be asked to submit a personal statement of up to 300 words. The Secretariat will then arrange for an election where members of the appropriate SIG will be invited to vote.
- The successful candidate/s will be elected by a simple majority of those members voting to the appropriate SIG Lead post.
BASL is committed to promoting equality, diversity and inclusion in all aspects of its work. It is actively promoting equal opportunities and access for all our members regardless of their background. We would, therefore, encourage you to consider this role to help shape the future of BASL and increase our inclusivity/inclusiveness.
Please contact sigs@basl.org.uk if you require any further information.
National Clinical Impact Awards 2026 - application deadline 5pm 20th May
Read moreThe National Clinical Impact Awards 2026 round opened on 1st April 2026.
The application window will remain open for seven weeks, closing at 17:00 on 20th May 2026.
Guidance for the 2026 National Clinical Impact Awards has been published here> Applying for a national Clinical Impact Award in 2026 - GOV.UK
A short guide for applicants can be found HERE.
Events
17/06/26
BASL School of Hepatology Webinar Series
We are delighted to announce the next webinar in our 2026 series:-
Title: “Autoimmune Hepatitis.. yes, it is sometimes difficult”
Date: Wednesday 17th June
Time: 19:00-20:00 UK
Speaker: Professor Dermot Gleeson
Format - a talk followed by a Q&A session
Platform - Zoom
FREE to attend for BASL Members and non-members. Catch up recording will only be available to BASL members.
You can read the BASL Events Data Protection Disclaimer via this link before registering: Download BASL Events Data Protection Disclaimer_2022.pdf
Contact: kim@basl.org.uk for any questions
BASL School of Hepatology Webinar Series is supported by sponsors including pharmaceutical companies. Pharmaceutical companies have solely provided financial sponsorship, with no input into the arrangements or agenda of the meeting. A full list of sponsors can be found below:
Registration is now open for the BSG Annual Meeting BSG LIVE'26, taking place 22 - 25 June 2026 at the ACC in Liverpool.
You can attend in-person, or virtually which provides you with access to 3 full live streams from the Tuesday to the Thursday of the conference, e-poster and on-demand content access.
This is a must-attend event for all healthcare professionals working in gastroenterology and hepatology, featuring:
Interactive Symposiums - covering all aspects of gastroenterology including dozens of CPD accredited sessions
Plenary Session - inspiring and thought-provoking sessions lead by experts in the speciality
Industry Lead Sessions - including an interactive exhibition where you can discover the latest developments in the industry
Scientific Poster Gallery - discover the latest research and clinical advances in gastroenterology including Flash Poster
Presentations taking place each lunchtime on a bank of mini stages
EndoVillage - open over 2 days where you can gain hands-on one-to-one training for an introduction to different endoscopic scenarios
Hybrid and On-Demand Content Library - take part in a number of parallel streams available to watch live throughout 3 days and 70+ hours of high-quality educational content available to watch on-demand
Make sure you secure your place before 27 April 2026 in order to save with the discounted early bird rate. You can register at https://live.bsg.org.uk/
This year's programme flatplan is now available to view here: https://live.bsg.org.uk/programme/
24/06/26 - 27/06/26
24 -27 June 2026 | Lille, France & Online
ESPGHAN 2026 is the premier global forum for presenting the latest advances in paediatric gastroenterology, hepatology, and nutrition. It offers a unique opportunity to learn from world-renowned experts in PGHaN care and research, build meaningful international connections, foster new collaborations, and advance your career.
This year’s meeting will highlight cutting-edge science across the basic, translational, and clinical spectrum of PGHaN, covering innovations in diagnosis, treatment, nutrition, liver disease, endoscopy, and global child health. The programme will also feature abstract presentations showcasing novel research discoveries that are transforming outcomes for infants, children, and adolescents worldwide.
Be part of the global PGHaN community at ESPGHAN 2026.
Key Dates:
Abstract Submission Deadline: 16 March 2026
Early Registration Deadline: 21 April 2026
For more information, visit the official website: https://espghancongress.org/
Registration now open
Don’t miss out — our last two events sold out with waiting lists. Secure your place early!
British Association for Allied Health Professionals in Liver (BAAL) are delighted to announce their 2026 annual face to face education meeting.
Date: 26th June 2026
Venue: The Edgbaston Park Hotel, University of Birmingham.
Topic: Living with Liver Disease: Redefining Healthcare Through the Power of the Patient Voice.
This year’s BAAL event brings patients and healthcare professionals together to strengthen and advance liver care. Celebrating the outstanding work already happening across the UK, the programme shines a spotlight on lived experience, showcases innovative multidisciplinary practice, and champions partnership driven improvements that enhance liver services nationwide.
Learning objectives:
- Gain insight into the lived experience of people with liver disease and how patient perspectives can shape better care.
- Explore practical ways to embed patient voice into clinical decision‑making, co‑design, and service improvement.
- Strengthen skills in working collaboratively with patients to understand barriers to medication adherence and support sustained engagement with treatment.
- Learn from multidisciplinary models that enhance supportive care and strengthen liver services across the pathway.
- Identify opportunities within their own organisations to improve care delivery, collaboration, and patient outcomes.
View a programme: Download BAAL 26th June 2026 agenda v8 docx.pdf
FREE to attend for BASL / BAAL members.
You can register HERE
Members will be asked for a £30 deposit on registration, which will be refunded when you attend the meeting.
The attendance fee for none members is £50 (non-refundable).
Not a member of BASL / BAAL? Please consider joining, it is £20 per annum for a Nurse/Affiliate membership.
Read more on the 'Join' webpage > Here and complete the application form > Here
If you require any further information please contact Kim@basl.org.uk
BAAL is supported by sponsors including pharmaceutical companies. Pharmaceutical companies have solely provided financial sponsorship, with no input into the arrangements or agenda of the meeting, except where indicated. A full list of sponsors can be found below and HERE
Save the Date
ArLD Special Interest Group Meeting
Date: 8th July 2026
Time: 1.30pm to 4.30pm
Platform: Zoom
SIG members - if you would like to add anything to the agenda please contact sigs@basl.org.uk
Registration Open - REGISTER > HERE
Open to BASL and BSG Members and SIG Members.
Quick Links
